AI and Data Science in Life Science Research: A Practical Guide for Scientists

AI and data science are no longer specialist skills confined to computational biology departments; they are core tools of the modern life science research workflow. From machine learning (ML) models that call genomic variants with atomic precision to deep learning pipelines that segment millions of cells in hours, the computational toolkit available to working scientists has expanded faster than any formal training curriculum has kept pace. This guide maps that landscape: what the tools are, where they genuinely deliver, and what skills matter for a research career in 2026.

How AI and data science are changing life science research

AI and data science now define how life science research is conducted, analyzed, and interpreted across disciplines, yet the terminology is used loosely enough that precision matters for scientists deciding where to invest their skills. In a research context, AI most commonly refers to ML models: algorithms that learn patterns from data rather than operating on explicit rules. Deep learning (DL) is a subset of ML that uses multi-layer neural networks and has driven most of the headline advances in genomics, structural biology, and imaging analysis over the past decade. Data science, used more broadly, encompasses the computational and statistical practices that allow researchers to extract insight from large, complex datasets.

The practical relevance for life scientists is that these tools now underpin many routine analytical tasks. Variant calling in genomic sequencing has shifted from rule-based algorithms toward DL models that treat the problem as an image classification task. Protein structure prediction, once the defining unsolved problem of structural biology, became practically tractable with the release of AlphaFold2 in 2021, which placed structures for nearly every protein in an open database accessible to any researcher. Cell segmentation in microscopy images, historically a manual and labor-intensive task, is now largely automated by generalist DL tools that outperform earlier specialist approaches across most imaging modalities.

What distinguishes the current moment from earlier waves of computational biology is accessibility. Tools that previously required substantial ML engineering expertise now run in interactive notebooks on institutional computing clusters or cloud environments. The conceptual barrier is more significant than the technical one: researchers who understand what a model is doing, what data it was trained on, and where its predictions are unreliable are in a far stronger position than those who treat these tools as black boxes.

Figure 1: Core application areas of AI and data science in life science research, highlighting key methods, representative tools, and primary research benefits across five distinct domains. Credit: AI-generated image created using Google Gemini (2026).

AI and machine learning in genomics and multiomics

Genomics generates more data per experiment than virtually any other life science discipline, and AI has become the primary analytical framework for most modern genomics workflows. Deep learning for variant calling (identifying single nucleotide variants and small insertions or deletions in sequencing data) has improved accuracy substantially over classical heuristic tools, particularly in genomic regions that are difficult to sequence reliably. Tools such as DeepVariant from Google reframe variant calling as an image classification problem applied to pileup representations of reads, a conceptual shift that proved highly effective.

Single-cell RNA sequencing (scRNA-seq) represents another area where AI has become indispensable. Experiments now routinely profile hundreds of thousands of individual cells, generating datasets that cannot be meaningfully interpreted without dimensionality reduction, unsupervised clustering, and cell type annotation, all tasks in which ML plays a central role. Methods for dimensionality reduction, most prominently UMAP (uniform manifold approximation and projection), introduced by McInnes and colleagues in a widely adopted algorithm paper, have become standard visualization tools in single-cell analysis. Downstream analytical steps, including pseudotime trajectory inference and cell-cell communication analysis, rely on probabilistic and ML-based frameworks.

The extension to multiomics integration, which combines genomic, transcriptomic, proteomic, and metabolomic data from the same samples or systems, presents harder computational challenges, in part because so much of the proteomic and metabolomic layer is generated through mass spectrometry-based separation science rather than sequencing. The datasets are heterogeneous in scale, format, and noise characteristics, and no universal integration framework dominates. Methods ranging from matrix factorization approaches such as MOFA+ to variational autoencoder-based models and graph neural networks (GNNs) each make different trade-offs between interpretability and expressive power. Researchers working at this interface should review the approaches available in their specific biological context rather than assuming any single method transfers cleanly. The depth and pace of change in this area make it one of the most actively developing intersections of AI and machine learning in genomics in the life sciences today.

Table 1: Common AI and ML approaches applied to genomics and multiomics data analysis, grouped by primary application.

Method	Primary application	Key tools
Deep learning variant calling	SNV and indel detection from sequencing reads	DeepVariant, DRAGEN
Dimensionality reduction	Visualization of high-dimensional single-cell data	UMAP, t-SNE, PCA
Clustering	Cell type identification in scRNA-seq	Leiden, Louvain, k-means
Matrix factorization and autoencoders	Multiomics integration, batch correction	MOFA+, scVI
Foundation models	Genomic sequence prediction and annotation	DNA-BERT, Nucleotide Transformer, Evo

Imaging AI and deep learning for biological microscopy

Biological imaging produces datasets whose scale and complexity human analysis cannot match in any modern high-throughput context. Deep learning has fundamentally changed what is computationally tractable in microscopy image analysis: cell segmentation, object detection and tracking, super-resolution enhancement, and high-content screening interpretation have all been transformed by DL-based methods over the past five years.

Cell segmentation, the process of delineating individual cells or nuclei from fluorescence or brightfield images, was previously the most time-consuming bottleneck in imaging pipelines. Generalist DL segmentation models now handle this reliably across a wide range of imaging modalities without requiring model retraining for each new experimental context. Cellpose, a generalist segmentation algorithm introduced by Stringer and colleagues, demonstrated that a single model trained on diverse cell types could outperform specialist models on unseen imaging data, as described in their landmark Nature Methods publication. Successor tools including Cellpose 2.0 and Cellpose 3, as well as SAM-based approaches, have extended performance further.

High-content screening (HCS), which generates millions of images per experimental campaign in drug discovery and cellular phenotyping applications, has made DL image analysis not optional but operationally necessary. Phenotypic profiling approaches including Cell Painting use AI to extract approximately 1,500 morphological features from multi-channel images, enabling compounds or genetic perturbations to be clustered by cellular phenotype without requiring predefined readouts. This is an area of substantial overlap between methods-focused research and applied drug discovery, and researchers using HCS platforms should understand both the computational pipeline and the biological interpretation layer.

Beyond segmentation, deep learning for super-resolution and image restoration has shifted practical trade-offs in microscopy. Content-aware image restoration (CARE) approaches use neural networks trained on paired low- and high-quality images to restore signal quality, enabling faster acquisition at lower laser power, which reduces phototoxicity in live-cell imaging experiments. Spatial transcriptomics, which maps gene expression to physical coordinates within tissue sections, has introduced a further analytical layer: spatial domain identification, deconvolution of cell types in bulk tissue measurements, and cross-modal integration of spatial data with histology images all rely on ML methods. Imaging AI and microscopy analysis represent one of the most technically diverse and rapidly evolving fronts in applied deep learning for biology.

Machine learning methods for life science data analysis

Machine learning methods are now embedded in life science data analysis at every scale, from individual variant calls in a single genome to phenotypic profiles across millions of cells, yet most life scientists have encountered them without formal training. Understanding the methods well enough to apply them correctly, evaluate their outputs critically, and recognize when they are being misused is now a practical research competency rather than a specialist skill.

The distinction between supervised and unsupervised learning maps onto a distinction researchers already understand intuitively. Supervised learning uses labeled training data to build a model that predicts an outcome of interest: predicting whether a cell is a particular type, whether a genomic variant is pathogenic, or whether a compound has a particular biological activity. Unsupervised learning finds structure in unlabeled data: clustering cells by expression profile, reducing high-dimensional data to a visualizable representation, or identifying latent factors that explain variation across samples. Most practical ML workflows in biology involve both at different stages.

Model evaluation is a discipline in itself and one where biological datasets present specific challenges. Class imbalance (rare variants, rare cell types, and rare positive hits in screening assays) is the norm rather than the exception in biology, and accuracy is often a misleading metric in imbalanced settings. Area under the receiver operating characteristic curve (AUC-ROC) and precision-recall curves provide more informative performance summaries for imbalanced classification problems. Cross-validation, particularly when applied to biological data with group structure such as patients, cell lines, or experimental batches, requires careful design to avoid data leakage that produces optimistically biased performance estimates.

Reproducibility is an active challenge in computational biology. Non-deterministic algorithms, undocumented software environments, and poorly described preprocessing steps have contributed to a literature in which published computational results are difficult to replicate. Practical tools including Snakemake and Nextflow for workflow management, Conda and Docker for environment reproducibility, and DVC for data versioning have made reproducible ML workflows substantially more achievable. Researchers building new ML workflows should treat these practices as standard from the outset rather than retrofitting them post-publication. Computational reproducibility and rigorous model evaluation for life scientists are the foundations on which credible ML-driven life science research rests.

The choice between classical ML methods and deep learning is itself a practical decision that many researchers approach poorly. Tree-based methods such as random forests and gradient boosting perform reliably on structured tabular biological data, are resistant to overfitting when properly tuned, and produce interpretable feature importance scores that connect computational output to biological meaning. Deep learning earns its added complexity only when the data volume, modality, or problem structure genuinely demands it: image data, raw sequence inputs, and problems requiring learned representations across millions of examples are appropriate use cases. Applying neural networks to small, well-annotated tabular datasets typically produces no benefit over simpler approaches and introduces unnecessary opacity.

Research data management for AI in life sciences

Research data management is the least glamorous and most consequential prerequisite for AI in life sciences: AI models only work on data that is well-organized, correctly annotated, and accessible in a consistent format. The gap between how most experimental data is currently managed and the state required for effective AI analysis is one of the most significant practical barriers to AI adoption in life science research.

The FAIR data principles (Findable, Accessible, Interoperable, and Reusable) were articulated by Wilkinson and colleagues in a foundational Scientific Data paper that has since become the reference framework for research data management across funders, publishers, and data repositories. FAIR is not a technical standard but a set of aspirational principles that describe what data needs to look like to be reliably discovered and reused. Implementing FAIR in practice requires decisions at the level of metadata schemas, controlled vocabularies and ontologies, persistent identifiers, and repository selection, all of which are now upstream of any AI analysis.

Funder mandates have accelerated the practical urgency of data management planning. The NIH Data Management and Sharing Policy, which became effective in January 2023, requires all NIH-funded research generating scientific data to include a data management and sharing plan with every application. Similar requirements from UKRI, Wellcome Trust, and the European Research Council mean that data management planning is now a condition of funding for most publicly funded life science research, not an optional best practice.

Electronic lab notebooks (ELNs) are the practical interface between experimental data collection and structured, AI-ready records. The shift from paper notebooks to ELNs matters for AI readiness because ELNs can enforce metadata capture at the point of data generation, link experimental conditions to results in machine-readable formats, and integrate with downstream analytical environments. Research data management is, in this sense, not a separate administrative task but an active component of experimental design, one that increasingly falls under the same lab management and automation strategy that governs instrumentation and workflows more broadly.

Metadata standards and ontologies are the layer beneath ELNs that determines whether data from different experiments, laboratories, or institutions can be meaningfully combined. Controlled vocabularies such as the Gene Ontology, the Cell Ontology, and the Human Phenotype Ontology allow biological concepts to be annotated consistently across datasets, making it possible for ML models to learn from aggregated data without being confounded by inconsistent terminology. Selecting the appropriate ontology for a given data type and applying it systematically at the point of data generation are practical skills that substantially increase the downstream value of experimental datasets for AI-driven analysis.

Large language models and generative AI in life science research

Large language models (LLMs) and generative AI tools have entered life science research workflows faster than any previous category of computational technology, and their scope extends well beyond text generation. Researchers now use them for literature mining, code generation, scientific writing assistance, and, in specialized biological forms, to predict protein properties from sequence alone. Understanding what these models can and cannot reliably do is now a core research literacy skill.

LLMs for scientific literature mining offer genuine utility: they can identify relevant papers across large corpora, summarize arguments, and extract claims from text at a speed no researcher can match. Tools built specifically for scientific literature including Semantic Scholar, Consensus, and Elicit apply LLM-based methods to structured scientific databases. The critical limitation is hallucination: LLMs generate plausible-sounding text that is not grounded in retrieved evidence, and they can confidently produce fabricated citations, incorrect statistical values, and non-existent experimental findings. Any AI-generated literature summary requires verification against primary sources before use in a manuscript or grant application.

Protein language models represent a distinct and scientifically substantive application of LLM-style architectures to biological sequences. Models including ESM2 from Meta AI's protein research team and ProtTrans from the Rostlab group are trained on protein sequence databases and learn to represent evolutionary and functional relationships from sequence alone, without explicit structural or functional labels. These representations can be applied to predict functional properties, identify sequence-fitness landscapes, and inform protein engineering efforts. They are conceptually and practically distinct from structure prediction models such as AlphaFold, and researchers working in protein science benefit from understanding how the two types of model complement each other across the growing landscape of large language models in research.

• Literature mining tools: help identify relevant papers, summarize arguments, and extract claims at scale, but require primary source verification before use in manuscripts.
• Code generation assistants: accelerate bioinformatics scripting but produce errors in biological data contexts that require careful validation, particularly for preprocessing and normalization steps.
• Protein language models: extract evolutionary and functional signal from sequence alone without explicit labels, with applications in fitness prediction and protein engineering.
• Generative protein design tools: design novel sequences to functional specifications, an application area that has moved rapidly from proof-of-concept to experimental validation.
• AI writing assistants: useful for drafting, editing, and restructuring prose but subject to hallucination and governed by evolving journal and funder policies that researchers must understand.

Data science and AI skills every life scientist needs

Data science and AI competency in life science research rests on a gap between biological domain knowledge and the computational literacy required to work with modern data, and closing it does not require every researcher to become a software engineer or ML specialist. It does require a baseline competency in scripting (Python or R), data wrangling, and the conceptual framework to understand what ML models are doing and when they should not be trusted. These skills are increasingly expected at all career stages, from graduate researchers to principal investigators.

Dimensionality reduction deserves particular attention as a skill area where misinterpretation is common and consequential. UMAP plots have become the default visualization in single-cell biology, but the clusters they display are shaped by hyperparameter choices, particularly the number of neighbors and minimum distance parameters, that can substantially alter apparent structure. A UMAP that looks like clean, distinct populations may reflect parameter choices rather than genuine biological heterogeneity. Researchers publishing single-cell analyses should understand these limitations and report their parameter choices transparently.

Version control, workflow management, and containerized environments are the computational infrastructure skills that most directly affect reproducibility. Proficiency with Git for version-controlled code, Snakemake or Nextflow for scripted pipelines, and Docker or Conda for environment management is now expected by reviewers at high-impact journals for computational biology papers and is becoming expected across the broader life science literature. Structured training resources from EMBL-EBI, The Carpentries, and the Turing Way project provide accessible entry points for researchers building these skills without formal computer science training.

Cloud computing has removed the hardware barrier that previously restricted large-scale computational biology to well-resourced institutions. Major commercial cloud platforms and institutional high-performance computing clusters allow researchers to run genome-scale analyses on demand without maintaining local infrastructure. Understanding the basics of cloud job submission, cost management, and data security is increasingly a practical requirement for life scientists working with sequencing, imaging, or multiomics datasets at scale. Browser-based interactive computing environments provide accessible on-ramps for researchers whose computational needs are growing beyond what a standard workstation can support.

AI and data science as essential tools for life science research

The framing of AI as an add-on technology that individual laboratories choose to adopt or avoid has become obsolete. In genomics, imaging, proteomics, and structural biology, AI-powered analysis is now the standard approach against which alternatives are measured. Researchers who do not engage with these tools risk misinterpreting published analyses, being unable to apply community-standard methods to their own data, and producing results that do not meet the computational rigor expected by reviewers and funders.

The more productive framing is one of infrastructure: like sequencing platforms or microscopes, AI and data science tools are research instruments with their own performance characteristics, failure modes, and skill requirements. Investing in the foundational literacy to use them critically, including understanding training data limitations, model uncertainty, and evaluation metrics, pays dividends across every domain of life science research.

This content includes text that has been created with the assistance of generative AI and has undergone editorial review before publishing. Technology Networks' AI policy can be found here.